G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $825,489 | -32.7% | 573,256 | +16.3% | 0.01% | -28.6% |
Q2 2023 | $1,227,012 | +61.6% | 492,776 | +74.0% | 0.01% | +40.0% |
Q1 2023 | $759,070 | +50.2% | 283,235 | +204.4% | 0.01% | +66.7% |
Q4 2022 | $505,240 | -60.5% | 93,046 | -9.2% | 0.00% | -70.0% |
Q3 2022 | $1,280,000 | -36.2% | 102,518 | -74.8% | 0.01% | -37.5% |
Q2 2022 | $2,006,000 | +732.4% | 406,064 | +3595.2% | 0.02% | +700.0% |
Q2 2021 | $241,000 | -74.5% | 10,989 | -72.0% | 0.00% | -71.4% |
Q1 2021 | $945,000 | -59.0% | 39,286 | -69.3% | 0.01% | -65.0% |
Q4 2020 | $2,304,000 | +61.8% | 128,083 | +3.9% | 0.02% | +33.3% |
Q3 2020 | $1,424,000 | +4.3% | 123,299 | +119.2% | 0.02% | 0.0% |
Q2 2020 | $1,365,000 | +273.0% | 56,258 | +69.5% | 0.02% | +200.0% |
Q1 2020 | $366,000 | +47.0% | 33,188 | +252.1% | 0.01% | +150.0% |
Q4 2019 | $249,000 | – | 9,427 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |